Industry reports
Editor highlights

Search inside this page

Free Market Research Guides to Download

Biopharmaceutical Analysis & Statistics in North America Countries, March 2012 (p7)

You might be interested in: biomedical, protein, antibody, more »

» Purchase Premium Reports

181-210 of about 300 reports
SunOpta BioProcess Inc. - Alternative Energy - Deals and Alliances Profile

SunOpta BioProcess Inc. - Alternative Energy - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2012
  • by Global Data

SunOpta BioProcess Inc. - Alternative Energy - Deals and Alliances Profile Summary SunOpta BioProcess Inc. (SunOpta) is engaged in designing, construction and operation of biomass conversion equipments. ...

  • Industries : Biopharmaceutical
  • Countries : Canada
Merger & Acquisition in Medical Equipment Industry: Omrix Biopharmaceuticals, Inc.

Merger & Acquisition in Medical Equipment Industry: Omrix Biopharmaceuticals, Inc.

  • $ 250
  • Company report
  • March 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Omrix Biopharmaceuticals, Inc: Pharmaceuticals and Healthcare Company Profile & SWOT Report

Omrix Biopharmaceuticals, Inc: Pharmaceuticals and Healthcare Company Profile & SWOT Report

  • $ 125
  • Company report
  • February 2012
  • by ICD Research

Synopsis ICD Research's "Omrix Biopharmaceuticals, Inc: Pharmaceuticals and Healthcare Company Profile & SWOT Report" contains in depth information and data about the company and its operations. The profile ...

  • Industries : Biopharmaceutical
  • Countries : United States, Israel
US Fat Replacers Industry

US Fat Replacers Industry

  • $ 4 500
  • Industry report
  • February 2012
  • by Global Industry Analyst

This report analyzes the US market for Fat Replacers in Thousand Metric Tons and US$ Million by the following Product Segments: Carbohydrate-Based Fat Replacers (Starch-Based Fat Replacers, & Hydrocolloid-Based ...

  • Industries : Sport Nutritional, Biopharmaceutical
  • Countries : United States
Biopharmaceutical Industry: Nabi Biopharmaceuticals - Strategy and SWOT Report

Biopharmaceutical Industry: Nabi Biopharmaceuticals - Strategy and SWOT Report

  • $ 175
  • Company report
  • December 2011
  • by MarketLine

The Nabi Biopharmaceuticals - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive industry player data and information. The market research report covers the firm ?s structure, operation, ...

  • Industries : Biopharmaceutical
  • Countries : United States
Nabi Biopharmaceuticals

Nabi Biopharmaceuticals

  • $ 175
  • Company report
  • December 2011
  • by MarketLine

Nabi Biopharmaceuticals - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings ...

  • Industries : Biopharmaceutical
  • Countries : United States
Nabi Biopharmaceuticals SWOT

Nabi Biopharmaceuticals SWOT

  • $ 175
  • Company report
  • December 2011
  • by MarketLine

examines the firm ?s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Nabi Biopharmaceuticals (Nabi) is engaged in the ...

  • Industries : Biopharmaceutical
  • Countries : United States
Monoclonal Antibodies Market to 2017 - Multiple Indication Approvals and the Potential for MAbs in Oncology and Autoimmune Diseases are Re-Shaping the Market

Monoclonal Antibodies Market to 2017 - Multiple Indication Approvals and the Potential for MAbs in Oncology and Autoimmune Diseases are Re-Shaping the Market

  • $ 3 500
  • Industry report
  • December 2011
  • by GBI Research

Monoclonal Antibodies Market to 2017 - Multiple Indication Approvals and the Potential for MAbs in Oncology and Autoimmune Diseases are Re-Shaping the Market Summary GBI Research, the leading business ...

  • Industries : Biopharmaceutical
  • Countries : World, United States, Europe
Enzymes: United States : Focus report

Enzymes: United States : Focus report

  • $ 600
  • Industry report
  • December 2011
  • by Freedonia Focus

Report Description This report discusses US enzyme demand for the years 2005 and 2010, with forecasts for 2015. Topics covered include market size, product and market segmentation, environmental and regulatory ...

  • Industries : Biopharmaceutical
  • Countries : United States
Next-Generation Antibody Therapies: Pipeline and Market 2011-2021

Next-Generation Antibody Therapies: Pipeline and Market 2011-2021

  • $ 2 621
  • Industry report
  • November 2011
  • by Visiongain

Report Details What are the prospects for emerging antibody technologies? Visiongain's report shows you potential revenues to 2021, discussing R&D trends and opportunities.  A new generation of therapeutic ...

  • Industries : Biopharmaceutical
  • Countries : United States
Dyax Corporation SWOT

Dyax Corporation SWOT

  • $ 175
  • Company report
  • October 2011
  • by MarketLine

examines the firm ?s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Dyax, a development stage biopharmaceutical firm ...

  • Industries : Biopharmaceutical
  • Countries : United States
Celgene Corporation SWOT

Celgene Corporation SWOT

  • $ 175
  • Company report
  • October 2011
  • by MarketLine

Celgene Corporation - SWOT Analysis industry player profile is the essential source for top-level industry player data and information. The market research report examines the firm ?s key business structure ...

  • Industries : Biopharmaceutical
  • Countries : United States
Biosimilar/Follow-on Biologics Market Report & Forecast: A Focus on the US (2011-2020)

Biosimilar/Follow-on Biologics Market Report & Forecast: A Focus on the US (2011-2020)

  • $ 1 200
  • Industry report
  • October 2011
  • by International Market Analysis Research and Consult

With sales worth US$ 57 Million in 2010, biosimilars are still far from their billion dollar sales potential that most analysts believe they will generate. This market, however, unlike small molecule generics, ...

  • Industries : Biopharmaceutical
  • Countries : United States
US Biologics  Market

US Biologics  Market

  • $ 4 900
  • Industry report
  • October 2011
  • by Freedonia

US demand to exceed $100 billion by 2015 Demand for biologics will exceed $100 billion in 2015, experiencing continuing strong growth following a decade of double-digit annual increases. Continued growth ...

  • Industries : Biopharmaceutical
  • Countries : United States
Global Protein Purification Reagents Market: An Expanding Role in Biopharmaceutical; Diagnostics; and Basic Biomedical Research

Global Protein Purification Reagents Market: An Expanding Role in Biopharmaceutical; Diagnostics; and Basic Biomedical Research

  • $ 6 000
  • Industry report
  • September 2011
  • by Frost & Sullivan

This research service analyzes the market for protein purification reagents with market sizing and forecasts for sales of tagged protein purification reagents and nontagged protein purification reagents. ...

  • Industries : Biopharmaceutical
  • Countries : World, United States
Intellect Neurosciences, Inc. (Symbol:ILNS) SWOT Analysis, Strategy, Revenues and Profits

Intellect Neurosciences, Inc. (Symbol:ILNS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 500
  • Company report
  • September 2011
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
RegeneRx Biopharmaceuticals, Inc. (Symbol:RGN) SWOT Analysis, Strategy, Revenues and Profits

RegeneRx Biopharmaceuticals, Inc. (Symbol:RGN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 250
  • Company report
  • September 2011
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : Australia, United States
Biopharmaceutical in United States: Micromet, Inc. ? Product Pipeline Review - H2 2011

Biopharmaceutical in United States: Micromet, Inc. ? Product Pipeline Review - H2 2011

  • $ 500
  • Company report
  • September 2011
  • by Global Markets Direct

s research and development focus. The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using ...

  • Industries : Biopharmaceutical
  • Countries : United States
Omrix Biopharmaceuticals, Inc.: Company Profile and SWOT Analysis

Omrix Biopharmaceuticals, Inc.: Company Profile and SWOT Analysis

  • $ 99
  • Company report
  • September 2011
  • by ICD Research

Synopsis ICD Research's "Omrix Biopharmaceuticals, Inc.: Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, ...

  • Industries : Biopharmaceutical
  • Countries : United States, Israel
Antibody-Drug Conjugates 2011 - real breakthrough still to come. A Technology, Stakeholder and R&D Pipeline Analysis

Antibody-Drug Conjugates 2011 - real breakthrough still to come. A Technology, Stakeholder and R&D Pipeline Analysis

  • $ 2 574
  • Industry report
  • September 2011
  • by La Merie Publishing

Product description This report ?Antibody-Drug Conjugates 2011 - real breakthrough still to come: A Technology, Stakeholder and R&D Pipeline Analysis? published in September 2011 provides the most complete ...

  • Industries : Biopharmaceutical
  • Countries : United States
Cephalon, Inc.- Strategy and SWOT Report

Cephalon, Inc.- Strategy and SWOT Report

  • $ 175
  • Company report
  • August 2011
  • by MarketLine

Cephalon, Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings ...

  • Industries : Biopharmaceutical
  • Countries : United States
Biopharmaceutical: Proteus Biomedical, Inc.

Biopharmaceutical: Proteus Biomedical, Inc.

  • $ 750
  • Company report
  • August 2011
  • by Global Data

This report is a source for data, analysis and actionable intelligence on the Proteus Biomedical, Inc. portfolio of new product development . The report provides detailed analysis on each pipeline product ...

  • Industries : Biopharmaceutical
  • Countries : United States
Biopharmaceutical in United States: Biosimilar: Regulatory Update

Biopharmaceutical in United States: Biosimilar: Regulatory Update

  • $ 395
  • Industry report
  • August 2011
  • by Datamonitor

About This Report Across the globe, regulators continue to develop the approval pathways and guidance regarding biosimilars. In the US, the FDA is currently consulting with various stakeholders regarding ...

  • Industries : Biopharmaceutical
  • Countries : United States, Brazil, Norway, Europe, World
Cephalon, Inc. - SWOT Analysis

Cephalon, Inc. - SWOT Analysis

  • $ 175
  • Company report
  • August 2011
  • by MarketLine

Cephalon, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. Cephalon, Inc. - SWOT Analysis examines the company's key business structure and operations, ...

  • Industries : Biopharmaceutical
  • Countries : United States
Actelion Ltd SWOT

Actelion Ltd SWOT

  • $ 175
  • Company report
  • August 2011
  • by MarketLine

examines the firm ?s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Actelion is a biopharmaceutical industry player focused ...

  • Industries : Biopharmaceutical
  • Countries : Switzerland, Australia, Brazil, Canada, Japan, World, Europe, United States
Micromet, Inc.- Strategy and SWOT Report

Micromet, Inc.- Strategy and SWOT Report

  • $ 175
  • Company report
  • July 2011
  • by MarketLine

Micromet, Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings ...

  • Industries : Biopharmaceutical
  • Countries : United States
Pfizer Inc. SWOT

Pfizer Inc. SWOT

  • $ 175
  • Company report
  • July 2011
  • by MarketLine

examines the firm ?s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Pfizer is the world's premier biopharmaceutical industry ...

  • Industries : Biopharmaceutical
  • Countries : United States
Micromet, Inc. SWOT

Micromet, Inc. SWOT

  • $ 175
  • Company report
  • July 2011
  • by MarketLine

examines the firm ?s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Micromet is a biopharmaceutical industry player focused ...

  • Industries : Biopharmaceutical
  • Countries : United States
Engineering Next-Generation Therapeutic Proteins: Trends and Markets To 2020 - Overview

Engineering Next-Generation Therapeutic Proteins: Trends and Markets To 2020 - Overview

  • $ 3 195
  • Industry report
  • July 2011
  • by CHI Insight Pharma Reports

By 2020, the current renaissance of biotechnology will have resulted in a broad range of products that will, almost without exception, involve a degree of protein engineering. This report discusses new ...

  • Industries : Biopharmaceutical
  • Countries : United States
The Coming Age of Biosimilars - Regulatory developments and alliance strategies intensify interest in a developing market

The Coming Age of Biosimilars - Regulatory developments and alliance strategies intensify interest in a developing market

  • $ 3 900
  • Industry report
  • May 2011
  • by CBR Pharma Insights

Biosimilars are attracting significant attention at present as companies from all sectors of the biopharmaceutical market are investigating the opportunities they present. Opinion is split as to the true ...

  • Industries : Biopharmaceutical
  • Countries : Europe, World, United States

» Read our Company Profiles

7 Companies

Johnson and Johnson

United States

Biogen Idec

United States

GlaxoSmithKline P.L.C.

United States

Amgen Inc.

United States

Merck KGaA

Germany

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.